TIRZ-2 60MG –  Research Material

Tirz Peptide is a research-use-only material containing tirzepatide, a peptide compound studied for its activity at the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. selectively activates both receptor pathways and is therefore an established subject of peptide, receptor, and metabolic research.

 Research

Tirzepatide has attracted significant scientific interest because of its dual GIP and GLP-1 receptor activity. Researchers investigate these pathways to better understand hormone signaling, receptor interactions, metabolic processes, and related biological mechanisms.

tirzepatide is presented as a research material for qualified laboratory and analytical applications. Appropriate research procedures, analytical methods, storage conditions, and handling protocols should be determined by qualified personnel according to institutional requirements and applicable regulations.

Research-Grade  Material

Clearly identified research materials are important for controlled laboratory investigations. TIRZ-2 60MG is intended for research involving peptide compounds, receptor biology, GIP and GLP-1 signaling, and related areas of scientific investigation.

Researchers should use appropriate laboratory equipment and established safety procedures when handling research materials. The suitability of this material for any particular experimental application should be determined by qualified laboratory personnel.

GIP and GLP-1 Receptor

Tirzepatide is a dual GIP and GLP-1 receptor agonist. Its activity at these two receptor systems makes it relevant to research into incretin signaling and associated biological pathways. FDA labeling describes  as selectively binding to and activating both GIP and GLP-1 receptors.

Research involving these receptor pathways can provide insight into hormone signaling, appetite-related biology, metabolic processes, and other areas of scientific investigation.

Laboratory Research Use Only

tirzepatide is supplied for research and analytical purposes only. It should not be marketed as a therapeutic product or represented as a substitute for an approved prescription medicine.

Tirzepatide is also the active ingredient in FDA-approved prescription medicines, including Zepbound. The FDA-approved products have specific formulations, indications, strengths, and prescribing requirements. Current FDA labeling lists approved single-dose strengths up to 15 mg and identifies 15 mg as the maximum recommended weekly dosage for Zepbound.

Accordingly, the 60MG product designation should not be interpreted as a human dosing recommendation.should remain clearly identified as a research material.

Research Applications

The dual-receptor activity of makes it a relevant compound for controlled investigations involving GIP and GLP-1 receptor biology. Researchers can study receptor interactions, signaling mechanisms, peptide characteristics, and related biological processes using appropriate laboratory methodologies.

tirzepatide provides a clearly identified research material for qualified laboratories conducting peptide and receptor-related investigations.

Important Research Notice

tirzepatide is intended for research purposes only. It is not intended for human or veterinary use, self-administration, diagnosis, treatment, cure, or prevention of disease.

Researchers should follow appropriate laboratory safety procedures, institutional requirements, and applicable regulations when handling this material. Unapproved versions of  have not undergone FDA review for safety, effectiveness, and quality before marketing.